Publications by authors named "Satoru Tanifuji"
Objective: Demand for erectile dysfunction treatments has increased not only in elderly patients but also in young patients. Reports indicate that frequent causes of erectile dysfunction in Japan are organic disorders in elderly patients and psychogenetic disorders in young patients.
Methods: We defined patients under the age of 40 as young erectile dysfunction patients, and those over 65 as elderly erectile dysfunction patients.
Objectives: To investigate the correlation between the Erection Hardness Score and both erectile function and metabolic and lifestyle factors.
Methods: This study included 548 men who underwent a complete standard medical checkup at Yokohama Shin-midori General Hospital between 1 July 2016 and 31 August 2018, and answered the question about erectile hardness. The following variables were evaluated: age, erectile hardness on the Erection Hardness Score, erectile function on the Sexual Health Inventory for Men, current medical history (diabetes, hypertension, dyslipidemia, heart disease, stroke), metabolic risk factors (abdominal circumference, hyperglycemia, high blood pressure, lipid abnormality) and lifestyle factors.
[INITIAL EXPERIENCE OF THE ENZALUTAMIDE TREATMENT FOR CASTRATION-RESISTANT PROSTATE CANCER].
Nihon Hinyokika Gakkai Zasshi
January 2016
Article Synopsis
- Enzalutamide is an oral medication that helps prolong survival in men with castration-resistant prostate cancer (CRPC) and was evaluated for its effectiveness and safety in a study of 73 patients.
- The study found that patients without prior docetaxel treatment had a better response to enzalutamide, with 61.4% achieving a significant reduction in PSA levels, compared to only 24.1% in those who had received docetaxel.
- Common side effects included fatigue, anorexia, and nausea, and some patients experienced a PSA flare, which can occur in those who respond to treatment.